Grifols’ combination treatment fails to meet endpoints in Covid-19 study,

Grifols has reported that the Phase III ‘Inpatient Treatment with Anti-Coronavirus Immunoglobulin’ (ITAC) clinical trial of a combination treatment …, Grifols has reported that the Phase III ‘Inpatient Treatment with Anti-Coronavirus Immunoglobulin’ (ITAC) clinical trial of a combination treatment …, Read More

Scroll to Top